Healthcare -
Biotechnology - NASDAQ - US
$ 63.34
-1.76 %
$ 3.48 B
Market Cap
-30.46
P/E
ACLX - STOCK-BASED COMPENSATION
Stock-based Compensation ACLX - Arcellx, Inc.
61.1 M
LAST VALUE
68.39%
2 YEAR CAGR
239.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR